Updated:
Cyanotech Corp
Cyanotech Corp is a publicly traded microalgae producer in Hawaii, cultivating Spirulina and astaxanthin for nutraceutical markets.
Cyanotech Corp
Cyanotech Corp is a publicly traded company (NASDAQ: CYAN) that cultivates and processes microalgae into nutritional products. Founded in 1983, the firm operates a 96-acre facility on the Kona coast of Hawaii, taking advantage of the region's consistent sunlight and pure ocean water to grow Spirulina and Haematococcus pluvialis algae (per company filings). Its two flagship brands, BioAstin and Hawaiian Spirulina Pacifica, sell through health food stores and online retailers worldwide. The company's products target the nutraceutical and dietary supplement sector, focusing on natural astaxanthin as a potent antioxidant and Spirulina as a protein-rich whole food. Revenue comes primarily from bulk powder sales to manufacturers and branded finished goods. The firm has invested in proprietary closed-system photobioreactor technology to increase yield consistency, though mass-market consumer awareness remains limited relative to larger supplement competitors. Cyanotech employs around 130 people and has maintained continuous production at its Kona facility since the 1990s. The company operates without a traditional family office structure — it is a public corporation with shareholders, not a private investment vehicle. No leadership details, AUM, or wealth origin are disclosed in the available public record. Structural differentiator: As a publicly traded algae producer, Cyanotech functions entirely as an operating company rather than an asset manager or family office. Its primary differentiator is the vertically integrated production from ocean-site cultivation through final product formulation, a model rare among listed small-cap agricultural biotech firms.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
What does Cyanotech Corp produce?
Cyanotech cultivates microalgae — specifically Spirulina (Arthrospira platensis) and Haematococcus pluvialis — into nutritional ingredients and finished supplements. Its primary products are BioAstin natural astaxanthin and Hawaiian Spirulina Pacifica, sold as powders, capsules, and extracts (per the firm's filings).
Is Cyanotech a family office or an operating company?
Cyanotech is an operating company — a publicly traded manufacturer of microalgae-based nutritional products (NASDAQ: CYAN). It does not function as a family office, investment vehicle, or asset manager. Public shareholders, not a family, control the entity.
Where is Cyanotech's production facility located?
The firm's sole production facility is located on 96 acres in Kailua-Kona on the Big Island of Hawaii. The location uses year-round sunlight and filtered Pacific Ocean water to support open-pond and closed-photobioreactor algae cultivation.
How does Cyanotech's technology differ from other algae producers?
Cyanotech employs a proprietary closed-system photobioreactor (PBR) technology for astaxanthin production alongside traditional open-pond Spirulina cultivation. This hybrid approach allows for controlled growth conditions and consistent year-round harvests, which the firm claims improves product purity and yield compared to competitors relying solely on open ponds.
Does Cyanotech have any known investment or family office connections?
No family office, private wealth management, or investment advisory relationships have been disclosed in public filings or credible media reports. Cyanotech is a standalone publicly traded company with no reported affiliation to high-net-worth families or institutional capital allocators outside its shareholder base.
What is the market for Cyanotech's products?
The company sells into the global dietary supplement and functional food markets, targeting health-conscious consumers seeking natural anti-inflammatory, antioxidant, or plant-based protein sources. Distribution spans the US, Europe, and Asia through B2B bulk powder sales and DTC online channels.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: